메뉴 건너뛰기




Volumn 29, Issue 12, 2009, Pages 5089-5094

Regulating immunity and inhibiting tumor growth by the recombinant peptide sPD-1-CH50

Author keywords

Domain; Fibronectin; Programmed death 1; Tumor immune therapy

Indexed keywords

ANTINEOPLASTIC AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; PROGRAMMED DEATH 1; PROTEIN CH 50; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

EID: 75149165611     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (19)

References (25)
  • 1
    • 0035902080 scopus 로고    scopus 로고
    • Progress in human tumor immunology and immunotherapy
    • Rosenberg SA: Progress in human tumor immunology and immunotherapy. Nature 411: 380-384, 2001.
    • (2001) Nature , vol.411 , pp. 380-384
    • Rosenberg, S.A.1
  • 2
    • 0036548986 scopus 로고    scopus 로고
    • Spinning molecular immunology into successful immunotherapy
    • Pardoll DM: Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol 2: 227-238, 2002.
    • (2002) Nat Rev Immunol , vol.2 , pp. 227-238
    • Pardoll, D.M.1
  • 3
    • 0034944615 scopus 로고    scopus 로고
    • Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma-infiltrating lymphocytes (TlL) implications for immunotherapy
    • Benlalam H, Labarrière N, Linard B, Derré L, Diez E, Pandolfino MC, Bonneville M and Jotereau F: Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma-infiltrating lymphocytes (TlL) implications for immunotherapy. Eur J Immunol 31: 2007-2015,2002.
    • (2002) Eur J Immunol , vol.31 , pp. 2007-2015
    • Benlalam, H.1    Labarrière, N.2    Linard, B.3    Derré, L.4    Diez, E.5    Pandolfino, M.C.6    Bonneville, M.7    Jotereau, F.8
  • 4
    • 0035340761 scopus 로고    scopus 로고
    • Tumor progression despite efficient tumor antigen cross presentation and effective 'arming' of tumor antigen specific CTL
    • Nelson DJ, Mukherjee S, Bundell C, Fisher S, Hagen D and Robinson B: Tumor progression despite efficient tumor antigen cross presentation and effective 'arming' of tumor antigen specific CTL. J Immunol 166: 5557-5566, 2001.
    • (2001) J Immunol , vol.166 , pp. 5557-5566
    • Nelson, D.J.1    Mukherjee, S.2    Bundell, C.3    Fisher, S.4    Hagen, D.5    Robinson, B.6
  • 10
    • 0037126021 scopus 로고    scopus 로고
    • Involvement of B7-H1 on tumor cells in the escape from host immune system and tumor immunotherapy by B7-H1 blockade
    • Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T and Minato N: Involvement of B7-H1 on tumor cells in the escape from host immune system and tumor immunotherapy by B7-H1 blockade. Proc Natl Acad Sci USA 199: 12293-12297, 2002.
    • (2002) Proc Natl Acad Sci USA , vol.199 , pp. 12293-12297
    • Iwai, Y.1    Ishida, M.2    Tanaka, Y.3    Okazaki, T.4    Honjo, T.5    Minato, N.6
  • 12
    • 6344240464 scopus 로고    scopus 로고
    • Blocking programmed death (PD)-ligand-PD-l interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine
    • He YF, Zhang GM, Wang XH, Zhang H, Yuan Y, Li D and Feng ZH: Blocking programmed death (PD)-ligand-PD-l interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J Immunol 173: 4919-4928, 2004.
    • (2004) J Immunol , vol.173 , pp. 4919-4928
    • He, Y.F.1    Zhang, G.M.2    Wang, X.H.3    Zhang, H.4    Yuan, Y.5    Li, D.6    Feng, Z.H.7
  • 13
    • 33646345848 scopus 로고    scopus 로고
    • HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma
    • Hui G, Zhang GM, Xiao H, Yuan Y, Li D, Zhang H, Qiu H, He YF and Feng ZH: HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int J Cancer 118: 2657-2664, 2006.
    • (2006) Int J Cancer , vol.118 , pp. 2657-2664
    • Hui, G.1    Zhang, G.M.2    Xiao, H.3    Yuan, Y.4    Li, D.5    Zhang, H.6    Qiu, H.7    He, Y.F.8    Feng, Z.H.9
  • 14
    • 23344452388 scopus 로고    scopus 로고
    • Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma
    • He LX, Zhang GM, He Y, Zhu H, Zhang H and Feng ZH: Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma. Anticancer Res 25: 3309-3313, 2005.
    • (2005) Anticancer Res , vol.25 , pp. 3309-3313
    • He, L.X.1    Zhang, G.M.2    He, Y.3    Zhu, H.4    Zhang, H.5    Feng, Z.H.6
  • 15
    • 0034047227 scopus 로고    scopus 로고
    • Comparison of effects of CH50 on macrophage activation and its antitumor activity with those of lipopolysaccharides
    • Zhang GM, Feng ZH, Li D and Zhang H: Comparison of effects of CH50 on macrophage activation and its antitumor activity with those of lipopolysaccharides. Acta Pharmacol Sin 21: 567-570, 2000.
    • (2000) Acta Pharmacol Sin , vol.21 , pp. 567-570
    • Zhang, G.M.1    Feng, Z.H.2    Li, D.3    Zhang, H.4
  • 16
    • 24944521955 scopus 로고    scopus 로고
    • Construction and expression of eukaryotic expressing vector pCH510 of polypeptide CH50 and its Chemotaxis and antitumor function by in vivo transfection
    • in Chinese
    • Li D, Feng ZH and Ye SQ: Construction and expression of eukaryotic expressing vector pCH510 of polypeptide CH50 and its Chemotaxis and antitumor function by in vivo transfection. J Tongji Med Univ 21: 1-5, 2001 (in Chinese).
    • (2001) J Tongji Med Univ , vol.21 , pp. 1-5
    • Li, D.1    Feng, Z.H.2    Ye, S.Q.3
  • 17
    • 38049074892 scopus 로고    scopus 로고
    • Recombinant CBD-HepII polypeptide of fibronectin inhibits αvβ3 signaling and hematogenous metastasis of tumor
    • Gong W, Liu Y, Huang B, Lei Z, Wu FH, Li D, Feng ZH and Zhang GM: Recombinant CBD-HepII polypeptide of fibronectin inhibits αvβ3 signaling and hematogenous metastasis of tumor. Biochem Biophys Res Commun 367: 144-149, 2008.
    • (2008) Biochem Biophys Res Commun , vol.367 , pp. 144-149
    • Gong, W.1    Liu, Y.2    Huang, B.3    Lei, Z.4    Wu, F.H.5    Li, D.6    Feng, Z.H.7    Zhang, G.M.8
  • 18
    • 34248579634 scopus 로고    scopus 로고
    • Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin
    • Liu Y, Huang B, Yuan Y, Gong W, Xiao H, Li D, Yu ZR, Wu FH, Zhang GM and Feng ZH: Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin. Int J Cancer 121: 184-192, 2007.
    • (2007) Int J Cancer , vol.121 , pp. 184-192
    • Liu, Y.1    Huang, B.2    Yuan, Y.3    Gong, W.4    Xiao, H.5    Li, D.6    Yu, Z.R.7    Wu, F.H.8    Zhang, G.M.9    Feng, Z.H.10
  • 19
    • 51749117557 scopus 로고    scopus 로고
    • Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host
    • Bhattacharyya N, Pal A, Patra S, Haldar AK, Roy S and Ray M: Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host. Int Immunopharmacol 8: 1503-1512, 2008.
    • (2008) Int Immunopharmacol , vol.8 , pp. 1503-1512
    • Bhattacharyya, N.1    Pal, A.2    Patra, S.3    Haldar, A.K.4    Roy, S.5    Ray, M.6
  • 22
    • 47049089532 scopus 로고    scopus 로고
    • Nitric oxide, apoptosis and macrophage polarization during tumor progression
    • Weigert A and Brüne B: Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19: 95-102, 2008.
    • (2008) Nitric Oxide , vol.19 , pp. 95-102
    • Weigert, A.1    Brüne, B.2
  • 23
    • 29644431786 scopus 로고    scopus 로고
    • Synergistic activation of macrophages via CD40 and TLR9 results in T-cell-independent antitumor effects
    • Buhtoiarov IN, Lum HD, Berke G, Sondel PM and Rakhmilevich AL: Synergistic activation of macrophages via CD40 and TLR9 results in T-cell-independent antitumor effects. J Immunol 176: 309-318, 2006.
    • (2006) J Immunol , vol.176 , pp. 309-318
    • Buhtoiarov, I.N.1    Lum, H.D.2    Berke, G.3    Sondel, P.M.4    Rakhmilevich, A.L.5
  • 24
    • 33751301603 scopus 로고    scopus 로고
    • Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages
    • Romieu-Mourez R, Solis M, Nardin A, Goubau D, Baron-Bodo V, Lin R, Massie B, Salcedo M and Hiscott J: Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res 66: 10576-10585, 2006.
    • (2006) Cancer Res , vol.66 , pp. 10576-10585
    • Romieu-Mourez, R.1    Solis, M.2    Nardin, A.3    Goubau, D.4    Baron-Bodo, V.5    Lin, R.6    Massie, B.7    Salcedo, M.8    Hiscott, J.9
  • 25
    • 33645086129 scopus 로고    scopus 로고
    • Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors
    • Xia D, Moyana T and Xiang J: Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors. Cell Res 16: 241-259, 2006.
    • (2006) Cell Res , vol.16 , pp. 241-259
    • Xia, D.1    Moyana, T.2    Xiang, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.